X @Wu Blockchain

Funding & Investment - Windtree Therapeutics (WINT), a Nasdaq-listed biotech company, secured up to $520 million in total funding [1] - The funding includes a $500 million equity line of credit (ELOC) agreement and an additional $20 million stock purchase deal [1] - Approximately 99% of the funds, equivalent to roughly $514.8 million, will be allocated to buy BNB (币安币) [1]